Announcement on Receiving Warning Letter from Zhejiang Office of China Securities Regulatory Commission

About this update from Zhejiang Hisun Pharmaceutical Co., Ltd. Class A

Announcement on Receiving Warning Letter from Zhejiang Office of China Securities Regulatory Commission The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang Hisun Pharmaceutical Co., Ltd. Class A